Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Argus Health
Julphar
Colorcon
Accenture
McKinsey
Daiichi Sankyo
Queensland Health
Healthtrust

Generated: November 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016885

« Back to Dashboard

NDA 016885 describes LYSODREN, which is a drug marketed by Laboratoire Hra and is included in one NDA. It is available from two suppliers. Additional details are available on the LYSODREN profile page.

The generic ingredient in LYSODREN is mitotane. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the mitotane profile page.
Summary for 016885
Tradename:LYSODREN
Applicant:Laboratoire Hra
Ingredient:mitotane
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 016885
Mechanism of ActionCytochrome P450 3A4 Inducers
Medical Subject Heading (MeSH) Categories for 016885
Suppliers and Packaging for NDA: 016885
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LYSODREN mitotane TABLET;ORAL 016885 NDA E.R. Squibb & Sons, L.L.C. 0015-3080 0015-3080-60 100 TABLET in 1 BOTTLE (0015-3080-60)
LYSODREN mitotane TABLET;ORAL 016885 NDA Laboratoire HRA Pharma 76336-080 76336-080-60 1 BOTTLE in 1 CARTON (76336-080-60) > 100 TABLET in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
UBS
Fish and Richardson
Fuji
Johnson and Johnson
Queensland Health
Farmers Insurance
US Army
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.